Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-11-21

Clinical Trial Update: Effect of Clarithromycin on the Pharmacokinetics of Apixaban in Healthy Participants [Phase 1]

View source ↗

Summary

Phase 1 study completed to assess how clarithromycin affects the pharmacokinetics of apixaban in healthy participants, evaluating a potential drug-drug interact…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Eliquis (apixaban)
  • clarithromycin (clarithromycin)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Venous Thromboembolism | Phase 1 | Status: COMPLETED